Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Rang în acțiuni #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Preț acțiune
$0.78611575
Capitalizare de piață
$60.45M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
-12.06%
Țară
NO
Tranzacționează Lytix Biopharma AS (LYTIX)

Categorie

Istoric al prețului acțiunii pentru Lytix Biopharma AS (LYTIX)
Cel mai mare preț de închidere: $0.83 pe 2026-08-01

Cel mai mic preț de închidere: $1.84 pe 2021-06-01
Istoric al prețului acțiunii pentru Lytix Biopharma AS din 2021 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -4.78%
2025 65.95%
2024 18.94%
2023 -38.40%
2022 -48.20%
2021 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$546.40 37.47%
US
$1.05K 57.85%
NL
$118.70 -18.24%
AU
$140.43 435.58%
US
$770.19 9.84%
CH